Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Cancer|March 1, 1977
Cell cycle parameters in human colon: comparison between primary and recurrent adenocarcinomas, benign polyps and adjacent unaffected mucosaH Bleiberg, A Salhadin, P Galand
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissuesH Bleiberg, M Morret, P Galand
Cancer|July 1, 1985
Cell kinetic indicators of premalignant stages of colorectal cancerH Bleiberg, M Buyse, P Galand
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in EuropeH Bleiberg, B Gerard, J Wils, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cancer Cooperative Group)P Rougier, C van Pottelsberghe, T Kok, et al.
Endoscopy|September 1, 1980
Laparoscopy in the diagnosis of liver metastases in 80 cases of malignant melanomaH Bleiberg, E La Meir, F Lejeune
Acta Gastro-Enterologica Belgica|May 1, 1989
[Adjuvant treatment in cancer of the stomach]G Popowski, H Bleiberg, P Van Houtte
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancerA Gerard, J C Pector, H Bleiberg
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Is overall survival a realistic primary end point in advanced colorectal cancer studies? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with CPT-11A Di Leo, M Buyse, H Bleiberg
British Journal of Cancer|January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancerC J Punt, E E Voest, E Tueni, et al.
Pageof 15